Accessibility Statement Skip Navigation
  • Back to Global Sites
  • +972-77-2005042
  • Blog
  • Journalists
  • GDPR
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • Telephone

    • +972-77-2005042 from 8 AM - 11 PM IL

    • Contact
    • Contact

      +972-77-2005042
      from 8 AM - 11 PM IL

  • Request More Information
  • Journalists
  • GDPR
  • Request More Information
  • Journalists
  • GDPR
  • Request More Information
  • Journalists
  • GDPR
  • Request More Information
  • Journalists
  • GDPR

Doug Brown, global nutrition industry veteran, appointed as new CEO Amai Proteins


News provided by

Amai Proteins

08 Sep, 2026, 16:00 IDT

Share this article

Share toX

Share this article

Share toX

Amai Proteins, an Israeli food-tech startup, has appointed Doug Brown as their new CEO, effective September 1st, 2026.

Amai's lead product, sweelin® is a next-generation sweet protein that enables significant sugar reduction and replaces conventional sweeteners with a protein-based alternative, designed to deliver superior clean taste, competitive cost, and improved formulation performance.

REHOVOT, Israel, Sept. 8, 2026 /PRNewswire/ -- Amai Proteins is taking another big leap towards scaling up the commercial traction for our lead product, sweelin® with the appointment of Doug Brown as new CEO, starting September 1st, 2026.

Doug Brown is a US national and brings decades of business development and leadership experience in the food, beverage and dietary supplement segments.

Continue Reading
Doug Brown, CEO Amai Proteins
Doug Brown, CEO Amai Proteins

Doug has worked in scale-ups as well as in multinational companies while being based in the US and in Europe. His career covers roles in food and beverage and dietary supplements, most recently as Chief Commercial Officer and Head of Global Account Management for Sirio Pharma and Best Formulations. He previously served as CCO for Clasado Biosciences (UK), and Head of Business Development for Nutritional Lipids at DSM Nutritional Products, in Switzerland.

"I am very excited to join the exceptional Amai Proteins team and help lead us into the next phase of growth. sweelin® is a perfect product at the right time for the GLP-1/peptide era," says Doug Brown.

Amai Proteins wishes to thank its outgoing CEO, Dr. Amir Guttman for navigating the company through an intense period of refocus. Amir will continue to contribute to Amai Proteins as an Executive Board Member.

About Amai Proteins

Amai Proteins develops, scales and commercializes proprietary sweet proteins for the food, beverage, and dietary supplement industries. The company's technology platform combines precision fermentation and advanced food technology to develop scalable, high-performance and great tasting protein ingredients.

Amai's lead product, sweelin®, is a monellin-based sweet protein inspired by the serendipity berry and is on average 3,000 times sweeter than sugar on a weight basis. The product is designed for stability, affordability, and compatibility with industrial food processing applications.

Produced through precision fermentation, sweelin® can be used in a wide variety of food & beverages, confectionery, chewing gum, condiments, and dietary supplements. Amai works with leading food and supplement manufacturers to enable up to 70% sugar reduction without compromising taste, cost, or sustainability.

For more information:

Doug Brown, CEO, Amai Proteins
[email protected]

SOURCE Amai Proteins

Modal title

Also from this source

Amai Proteins' sweelin® Approved for Sale in Israel, Opening the Market to a New Generation of Reduced-Sugar Food and Beverage Products

Amai Proteins announces that the Israeli Ministry of Health has officially approved sweelin® as a novel food ingredient for use in a broad range of...

sweelin® Clinical Trial Results Published in Leading Journal, Food Chemistry, Confirming Blood Glucose Safety

Amai Proteins announces another milestone for sweelin®. The world's first human clinical trial on the metabolic effects of sweet proteins is now...

More Releases From This Source

Explore

Food & Beverages

Food & Beverages

Fitness/Wellness

Fitness/Wellness

Beverages

Beverages

Biotechnology

Biotechnology

News Releases in Similar Topics

Contact PR Newswire

  • +972-77-2005042
    from 8 AM - 11 PM IL

Global Sites

  • APAC
  • APAC - Traditional Chinese
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany

 

  • India
  • Indonesia
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland

 

  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921
Global Sites
  • Asia
  • Brazil
  • Canada
  • Csezh
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italie
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
+972-77-2005042
from 8 AM - 11 PM IL
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2026 Cision US Inc.